The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

A new antibody shot could help infants who contract respiratory ... significant lasting difference in what RSV, how it impacts our community." The treatment is also recommended for older adults ...

Most treatments are supportive ... RSV disease Pregnant women during weeks 32-36 of pregnancy Infants can be protected from RSV early in life with an RSV antibody given soon after they're born.

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

It is estimated that an average of 33 children under five years old die from RSV in the UK each year 7. There is no effective specific drug treatment for RSV and as a result, the mainstay of ...

The market for RSV treatments currently has only one, narrowly defined patient group: prematurely born infants at high risk of infection, who can be treated with immunoprophylactic antibodies.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

Young children with chronic conditions are more likely to be hospitalized for respiratory syncytial virus (RSV) than healthy children, according to a new study.

A  scientific forum held in HCM City on April 27 announced a pioneering preventive method to help prevent lower respiratory ...

RSV is a major respiratory pathogen, particularly among young children, causing severe lower ... ribavirin—an antiviral previously used for RSV treatment—showed minimal efficacy.

With millions of cases annually worldwide, especially among infants under six months, RSV imposes a significant burden on families and healthcare systems. Current treatments are limited to ...

Researchers have targeted an RSV vaccine since the 1960s ... called nirsevimab as a preventative treatment that works like a vaccine to protect babies and toddlers. The EU had already approved ...